key: cord-0047052-vpivq5gy
authors: Steiner, Ursula
title: Biotechnology
date: 2020-07-07
journal: Fachenglisch für BioTAs und BTAs
DOI: 10.1007/978-3-662-60666-7_1
sha: f839b949710833512e9641307585b845456cc441
doc_id: 47052
cord_uid: vpivq5gy

Biotechnology derives from the Greek words – bios – life, technos – technology and logos – language, proof – that is biotechnology deals with the technical usage of living organisms for various purposes such as food, medicine, pharmaceuticals, recycling. Nowadays we deal with various colours or categories namely 10 introduced (red, blue, green, white, grey, yellow, brown, violet, dark and gold biotechnology) by Dr. Rita R. Colwell in 2003 and presented in this book. Other categories are also in use, the division into plant biotechnology, animal biotechnology, biotechnology of microorganisms and its colonies, cell culture biotechnologies, biotechnology of subcellular systems. The word ‘biotechnology’ was used for the first time by the director of the cattle utilization cooperative and Hungarian great land owner Karl Ereky and latter Hungarian Food minister. He published a book with the title: “Biotechnology of the meat, fat and milk production in agricultural large concerns for scientific sophisticated farmers” in 1919 in Berlin. His idea was to produce consumer goods with the use of living organisms called biotechnology. That was nothing new, but the word was new.

Biotechnology derives from the Greek words -bios -life, technos -technology and logos -language, proof -that is biotechnology deals with the technical usage of living organisms for various purposes such as food, medicine, pharmaceuticals, recycling. Nowadays we deal with various colours or categories namely 10 introduced (red, blue, green, white, grey, yellow, brown, violet, dark and gold biotechnology) by Dr. Rita R. Colwell in 2003 and presented in this book. Other categories are also in use, the division into plant biotechnology, animal biotechnology, biotechnology of microorganisms and its colonies, cell culture biotechnologies, biotechnology of subcellular systems. The word 'biotechnology' was used for the first time by the director of the cattle utilization cooperative and Hungarian great land owner Karl Ereky and latter Hungarian Food minister. He published a book with the title: "Biotechnology of the meat, fat and milk production in agricultural large concerns for scientific sophisticated farmers" in 1919 in Berlin. His idea was to produce consumer goods with the use of living organisms called biotechnology. That was nothing new, but the word was new.

So lets immerse in the world of biotechnology which is as colourful and fascinating as life itself.

Red biotechnology deals with biotechnological techniques such as gene therapy (replacing a defective gene causing diseases by a healthy gene), stem cell research (to fight off leukaemia), genetic engineering (changing the genetic makeup of genes to produce improved organisms) and the development of new drugs and vaccines in medicine.

Another inventive application is tissue engineering. That means that cells are cultivated for tissue implantation. This leads to the production of artificial skin, cartilage and spinal disc replacement.

Furthermore red biotechnology finds also its application in the field of research about mutations and amplifications of genes to cure degenerative diseases such as Parkinson.

It is commonly known that certain drugs are not so effective for every patient because of its genetic disposition and metabolism. Therefore knowing the genetic disposition of a patient implies a better treatment by the analysis of the genes.

In conclusion red biotechnology means an immense progress in medicine which still has to be developed further.

By analysing some texts about red biotechnology pupils can gain a better inside. Listen to the youtube video: www.youtube.com/watch?v=hv1U19J3yfw Introduction to red biotechnology and biopharmaceuticals Note five keywords and explain them more closely. 

Parkinson's disease is one of the most common neurodegenerative diseases in the world. There are around 4.3 million sufferers worldwide. It is characterised by motor impairments that result from the death of certain nerve cells in the brain. Therapies are not yet available. However, researchers at the University of Tübingen have now discovered that vitamin B3 has a positive effect on damaged nerve cells and can boost their energy metabolism. Vitamin B3 application will now be examined to determine whether it could be a new therapeutic approach for treating Parkinson's. Parkinson's is the second most common neurodegenerative disease after Alzheimer's. The disease affects around two percent of people over 60 worldwide, and the numbers are rising. Between 250,000 and 280,000 people have the disease in Germany alone. Typical symptoms of this still incurable disease include motor impairments such as unsteady hands, stiff muscles and slow movements. The disease is caused by the loss of dopamine-containing nerve cells in a certain brain region called the black substance (substantia nigra). Little is yet known why these nerve cells die.

For many years, junior professor Dr. Dr. Michela Deleidi and her research group at the Hertie Institute for Clinical Brain Research and the University of Tübingen have been studying how Parkinson's disease develops. "Some time ago, we came up with the idea that the disease is caused by damaged nerve cells with a dysfunctional energy metabolism, and hence damaged mitochondria," explains Deleid1. "And indeed, in one of our studies, we found that the mitochondria in the affected nerve cells of Parkinson's patients did not work properly. So we then decided to look for a way to repair and improve mitochondrial function."

In search of a "mitochondrial rescue", as Deleidi calls it, the researchers came across vitamin B3. "It has long been known that vitamin B3 plays a role in central metabolic processes, and some studies have shown that the vitamin plays a role in maintaining healthy mitochondria," says the neurologist. "So it was natural for us to look at the vitamin and its potential role in the treatment of Parkinson's."

The scientists took skin cell samples from patients with Parkinson's, 1.e. patients that carried a defect in the so-called GBA * gene, in order to find out whether damaged mitochondria cause Parkinson's disease. A mutation in this gene is one of the major risk factors for Parkinson's disease. After removal, the cells were converted into stem cells using protocols that were developed specifically for this purpose. "All artificial nerve cells had a characteristic mutation in the GBA gene, which is the most frequent risk gene for Parkinson's," says Deleidi "And we were able to show that the mitochondria and energy metabolism of these cells were impaired."

The scientists from Tübingen subsequently treated the damaged cells with a vitamin B3 variant. "And fortunately, we were able to eliminate most of the cells' abnormalities," said the junior professor. "In the flies that we were using as models of ageing, we even found that the sought after compound is a true anti-ageing product." The researchers, who are part of an international research consortium, took flies of the genus Drosophila that had a defective GBA gene and hence problems moving around, and fed them the vitamin B3 variant to boost the formation of new mitochondria. "And there too, we were able to show that the vitamin considerably improved neuronal functions and behaviour," says Deleid1.

The researchers did not use vitamin B3 -the nicotinamide -for the investigations, but a variant of the vitamin called nicotinamide riboside. The latter is the precursor of the coenzyme NAD (nicotinamide adenine dinucleotide), which plays an important role in many metabolic processes involved cellular energy production. "We now know that the administration of the vitamin B3 variant nictoinamide riboside leads to the elevation of the intracellular NAD level and hence to considerable improvement of many biological processes, including microchondrial function and cellular energy generation," said the researcher. "Our experiments suggest that the loss of mitochondria does indeed play a significant role in the development of Parkinson's disease."

Vitamin B3 -A Universal Anti-Ageing Product? Administering nicotinamide riboside may be a new starting point for treating Parkinson's. "At present, several clinical trials involving healthy volunteers and people with other mitochondrial diseases are underway." "The goal is to find out how the vitamin B3 variant works", says Deleid1. "While we are waiting for these results to be available we will continue characterising the substance and its metabolism in greater detail. Previous studies indicate that the vitamin B3 variant does not lead to serious adverse effects. However, the dosage will have to be very high because the drug needs to be taken orally. I am often asked by patients if they can start taking the substance. But I think that we need more results before giving the go-ahead for this."

The researchers are already working with ChromaDex on the optimisation of nicotinamide riboside. ChromaDex is an American company that specialises in phytochemicals and has already supplied the Tübingen researchers with nicotinamide riboside for a recently completed study. "In addition to our previous findings, the study shows that our approach is not only specifically directed at the age-related degradation of metabolic processes in the human body, which includes Alzheimer's, muscle loss and eye problems," says Deleid1. And the sooner you can do something about this, the better. If the outcome of the clinical trials is positive, vitamin B3 would really have what it takes to become the new "anti-ageing pill".

* GBA = Genombezeichnung Make up a sentence with four words of the table: e.g. Many researchers were involved in this project.

State the name of the tenses, give reasons why they were used:

1. Researchers at the University of Tübingen have now discovered that vitamin B 3 has a positive effect on damaged nerve cells. 2. For many years researchers have been studying how Parkinson's disease develops. 3. While we are waiting for these results to be available we will continue characterising the substance and its metabolism in greater detail. 1. There has been no therapy so far against Parkinson.

2. The mutation of the GBA gene is the main risk factor for Parkinson.

3. The scientists are already working on an optimisation of the therapy.

4. The scientific approach is not only directed for Parkinson, but also for all other diseases. Green, red, white and blue -the colours of biotechnology. Blue, 1.e. marine biotechnology, is one of the less known branches. Biotechnological methods are used to investigate marine life and the results obtained from these investigations advance research in the fields of medicine and energy and into substances used as food supplements and cosmetics. The area of marine biotechnology is fairly diverse. Although it is not on the coast, even the southern German state of Baden-Württemberg is involved in marine biotechnology. The sea -the yrr * invented by German science fiction author Frank Schätzing live in it, Jules Verne's protagonists travel 20,000 leagues under it and SpongeBob's pineapple house sits on its bed. Only around one percent of the ocean has been studied, which is why a lot of myths, speculation and fairytales revolve around it. However, new terms like "drugstore from the bottom of the sea" or "marine pharmacy" have started to be bandied around. Marine microorganisms have had around three billion years more to develop than life on land. They have adapted to extreme environmental conditions in the sea -from the cold of the Antarctic ice to the hot, bubbling deep-sea volcanoes. This is where biotechnology comes in, or rather marine biotechnology, to be more exact. Marine biotechnology is the application of science and technology to marine organisms. Marine microbes, sponges and algae produce substances that have been found to be effective against cancer and AIDS, they are also likely to become important providers of energy, they are used to produce substances such as glass or to obtain important knowledge for the production of new washing detergents active at lower temperatures.

Some pharmaceutical substances isolated from marine organisms have already been placed on the market. Rather like tiny factories embedded in coral reefs, cyanobacteria, also known as blue algae, are among the most important producers of a broad range of different substances (more than 200), including bioactive with antitumour, antibiotic, anti-inflammatory and antiviral effect.

Yrr * -fictious, marine, unicellular jelly-like life form whose mission is to eliminate the human race by devasting the Earth's oceans. The protagonist of the novel, Norwegian scientist Sigur Johanson, calls this life form "yrr", a name he created by typing three letters at random on his keyboard (eds. note).

Algae have the potential to be used in many different areas. They produce hydrogen, which will make them important sources of energy in the future; algae genes are transferred into soy and rapeseed, where they lead to the increased production of omega-3 fatty acids, essential fatty acids that cannot be synthesised by the human body, but are vital for normal metabolism. Researchers also focus on marine sponges, small sessile animals that have colonised the oceans for around 800 million years and developed an arsenal of mechanisms to defend themselves against predators.

The substances, which scare predators off rather than killing them, contain toxic and pharmaceutically active substances which are now used in cancer research, in particular in leukaemia research.

Only a small fraction of biotechnological research -around one percent -involves marine organisms. Marine research is very expensive and the prospect of commericialising new discoveries is still a distant dream. The coastal states of Bremen and Schleswig-Holstein are leaders in the field of marine biotechnology in Germany. The Helmholtz Centre for Ocean Research in Kiel -GEOMAR -investigates the chemical, physical, biological and geological processes of all marine habitats and is also active in the field of marine microbiology. "Many of our projects are focused on marine microorganisms from which we can isolate natural substances. We are also very much focused on turning our research results into marketable commodities," said Johanna Silber of GEOMAR, going to add that GEOMAR has already identified a number of marine microbial compounds that are used in cosmetics, antibiotics and even pesticides.

Despite the fact that Baden-Württemberg is not on the coast, the marine life sciences branch is nevertheless represented here in the form of sponge and algae projects. Even a sponge species was discovered in Baden Württemberg: Tethya wilhelma was discovered and characterised by Franz Brümmer and Dr. Michael Nickel in the zoo "Wilhelma" (Stuttgart) around ten years ago. The small, white sponge is ball-shaped. But what differentiates it from all other sponge species is that it is able to move around.

Researchers at the Karlsruhe Institute of Technology are focused on marine sponges and algae. Using Aplysina aerophoba, also known as Gold-sponge, as a model organism, Christoph Syldatk and his team are studying the metabolite production of ex situ sponge cultures. They are particularly interested in improving the cultivation of sponges from a biotechnological point of view. Cultivating sponges with the aim of producing bioactive substances in relatively large quantities has always been very difficult.

Aplysina aerophoba is a common sponge in the Mediterranean. It is of great interest to researchers due to its ability to produce the pharmaceutically active substance aeroplysinin-1 as a natural metabolite. The brominated low-molecular metabolite has an antibacterial effect and also impairs the growth of tumor cells. Although aeroplysinin-1 is commercially available, it still needs to be extracted from sponges. Sponge-associated microorganisms have also been found to produce some of the bioactive natural substances that were previously thought to have been produced by the sponge.

The energy sector is another important area of application for marine biotechnology. When energy is scarce, people tend to clamour for new, efficient and environmentally friendly energy carriers. In addition, new energy sources must have an environmentally friendly CO2 balance and must not use land set aside for agriculture. Algae could be a way out of this situation. Algae are relatively versatile; they can be used as food supplements and to produce biodiesel, oil and bioethanol. In addition, algal bioreactors like the ones produced by Baden-Württemberg-based Subitec GmbH can be set up anywhere. Subitec optimises its bioreactors for the cultivation of marine and freshwater algae according to the specific requirements of its clients. Many products can be produced with algae, including substances used as food supplements or in the cosmetics industry. Dr. Peter Ripplinger, CEO of Busitec, also points out that raw materials such as carbohydrates and lipids could be produced with algae as energy producers." Future energy production will not be dominated by rapeseed; I firmly believe that the future production of energy from biomass will be based on algae", said Ripplinger.

Algae bind CO2 as they grow. However, this CO2 is released when energy is produced. Algae can therefore be characterised as CO2 neutral. However, they can do even better than that: Prof. Clemen Posten and his team at the Karlsruhe Institute of Technology are working on bioprocesses that enable them to cultivate the green alga Chlamydomonas reinhardtii in a way that triggers it to produce environmentallyfriendly hydrogen, both more cheaply and more energy efficiently than has been possible up until now.

Marine waste can be further processed using biotechnological methods. Chitin, which is found in the shells of shellfish that are removed prior to being packed and sold -quantities of around 750,000 t of shells per year are removed in Europe -is already being converted into chitosan in Asia. Chitosan is still very much in its infancy in Europe. The shells of European shellfish contain too much chalk which renders the further processing of chitin into chitosan uneconomical. However, the "ChiBo" project, which is funded under the European 7th Framework Programme, is seeking to improve the situation.

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart is part of the project and is focused on the development of enzymes that degrade chitin into monomers. Dr. Antje Laber (GEOMAR) does not regard marine biotechnology as a different branch of traditional biotechnology. "We are working with the same methods, devices and principles as the other branches. The only difference is that we are working with algae. I imagine that the potential of new characteristics and potentials offered by marine substances will in future become an integral part of classical biotechnology," Laber said. And what this means in concrete terms is that marine biotechnology can support and stimulate the other branches of biotechnology with its findings.

1. State at least two advantages and disadvantages of blue biotechnology. Draw a conclusion! 2. Explain the advantages of algae in comparison to other fuels. 3. Name at least one application of blue biotechnology * in the field of: a) research b) medicine c) pharmaceutical use d) waste recycling e) cosmetics Complete your answers by doing research in the internet. State your sources! * 4. Find out five facts about GEOMAR! 5. Give a closer definition of chitin! *

Find five facts about these marine organisms in the field of biotechnology: * Cyanobacteria Sponges Algae 

Find out which relationship they have with blue biotechnology. E.g. can they be used as pharmaceuticals for medical research or as biofuel?

Find 5 adjectives in the text: F ind 5 adverbs in the text:

1. Make up a sample sentence with each. 2. Describe one biotechnological tool, biotechnological product or a biotechnological marine organism with at least 5 adjectives or 5 adverbs.

Scrambled words: Put the letters into the right order pssgnoe essieel sprdarote ticaaqu rasetbetrev

Put the sentences into the right order 1. temperature -light -vary on -habitats -currents -salinity.

2. the shore -live -most -to -invertebrates -close -marine.

3. float -to swim -not -able -plankton -they -with -the current -are 4. live -such as -seabirds -on -but -and -go to -pelicans -sea -land 

Green biotechnology mainly deals with the genetic modification of plants to make them more drought resistant or to strengthen certain characteristic traits to receive a better yield or to make them resistant to viral diseases. Furthermore it also stands for the development of biopesticides and biofertilizers to reduce the chemical impact of nitrogen on the environment.

Breeding hybrids is a further field of green biotechnology e.g. tomatoes are more long-living than normal tomatoes due to hybridization. Green biotechnology is the topic which is discussed about worldwide due to ethical and moral issues. The idea was greeted skeptically in scientific circles and ignored by funding agencies. But one outfit with deep pockets, the Bill and Melinda Gates Foundation, eventually paid attention, hoping the research might help alleviate global poverty. Now, after several years of work funded by the foundation, the scientists are reporting a remarkable result.

Using genetic engineering techniques to alter photosynthesis, they increased the productivity of a test plant -tobacco -by as much as 20 %, they said Thursday in a study published by the journal Science. That is a huge number, given that plant breeders struggle to eke out gains of 1 or 2 % more conventional approaches.

The scientists have no interest in increasing the production of tobacco; their plan is to try the same alterations in food crops, and one of the leaders of the work belie- ves production gains of 50 % or more may ultimately be achievable. If the prediction is borne out in further research -it could take a decade, if not longer, to know for sure -the result might be nothing less than a transformation of global agriculture. The findings could also intensify the political struggle over genetic engineering of the food supply. Some groups oppose it, arguing that researchers are playing God by moving genes from one species to another. That argument has gained some traction with the public, in part because the benefits of gene-altered crops have so far been modest at best. But gains of 40 or 50 % in food production would be an entirely different matter, potentially offering enormous benefits for the world's poorest people, many of them farmers working small plots of land in the developing world.

"We're here because we want to alleviate poverty," said Katherine Kahn, the officer at the Gates Foundation overseeing the grant for the Illinois research. "What is it the farmers need, and how can we help them get there?"

One of the leaders of the research, Stephen P. Long, a crop scientist who holds appointments at the University of Illinois at Urbana-Champaign and at Lancaster University in England, emphasized in an interview that a long road lay ahead before any results from the work might reach farmers' fields.

But Dr. Long is also convinced that genetic engineering could ultimately lead to what he called a "second Green Revolution" that would produce huge gains in food production, like the original Green Revolution of the 1960s and 1970s, which transferred advanced agricultural techniques to some developing countries and led to reductions in world hunger.

The research involvers photosynthesis, in which plants use carbon dioxide from the air and energy from sunlight to form new, energy-rich carbohydrates. These compounds are, in turn, the basic energy supply for almost all animal cells, including those of humans. The mathematical description of photosynthesis is sometimes billed as "the equation that powers the world."

For a decade, Dr. Long had argued that photosnythesis was not actually very efficient. In the course of evolution, several experts said, Mother Nature had focused on the survival and reproduction of plants, not on putting out the maximum amount of seeds or fruits for humans to come along and pick.

Dr. Long thought crop yields might be improved by certain genetic changes. Other scientists doubted it would work, but with the Science paper, Dr. Lang and his collaborator -Krishan K. Niyogi who holds appointments at the University of California, Berkeley, and the Lawrence Berkeley National Laboratory -have gone a long way toward proving their point.

Much of the work at the University of Illinois was carried out by two young researchers from abroad who hold positions in Dr. Long's laboratory, Johannes Kromdijk of the Netherlands and Katarzyna Glowacka of Poland.

No one plans to eat tobacco, of course, nor does the Gates Foundation have any interest in increasing the production of that health-damaging crop. But the resear-chers used it because tobacco is a particularly fast and easy plant in which to try new genetic alterations to see how well they work.

In a recent interview here, Dr. Kromdijk and Dr. Glowacka showed off tiny tobacco plants incorporating the genetic changes and described their aspirations.

"We hope it translates into food crops in the way we've shown in tobacco," Dr. Kromodijk said. "Of course, you only know when you actually try it."

In the initial work, the researchers transferred genes from a common laboratory plant, known as thale cress or mouse-ear cress, into strains of tobacco. The effect was not to introduce alien substances, but rather to increase the level of certain proteins that already existed in tobacco.

When plants receive direct sunlight, they are often getting more energy than they can use, and they activate a mechanism that helps them shed it as heat -while slowing carbohydrate production. The genetic changes the researchers introduced help the plant turn that mechanism off faster once the excessive sunlight ends, so that the machinery of photosynthesis can get back more quickly to maximal production of carbohydrates.

It is a bit like a factory worker taking a shorter coffee break before getting back to the assembly line. But the effect on the overall growth of the tobacco plants was surprisingly large.

When the scientists grew the newly created plants in fields at the University of Illinois, they achieved yield increases of 13.5 % in one strain, 19 % in a second and 20 % in a third, over normal tobacco plants grown for comparison.

Because the machinery of photosynthesis in many of the world's food crops is identical to that of tobacco, theory suggests that a comparable manipulation of those crops should increase production. Work is planned to test that in crops that are especially important as dietary staples in Africa, like cowpeas, rice and cassava.

Two outside experts not involved in the research both used the word "exciting" to describe it. But they emphasized that the researchers had not yet proved that the food supply could be increased.

"How does it look in rice or corn or wheat or sugar beets?" said L. Val Giddings, a senior fellow at the Information Technology and Innovation Foundation in Washington and a longtime advocate of gene-altered crops. "You've got to get into a handful of the important crops before you can show this is real and it's going to have a huge impact. We are not there yet." Barry D. Bruce of the University of Tennessee at Knoxville, who studies photosynthesis, pointed out that the genetic alteration might behave differently in crops where only parts of the plant, such as seeds or fruits, are harvested. In tobacco, by contrast, the entire aboveground plant is harvested -Dr. Bruce called it "a leafy green plant used for cigars!"

Dr. Bruce also noted that, now that the principle has been established, it might be possible to find plant varieties with the desired traits and introduce the changes into crops by conventional breeding, rather than by genetic engineering. Dr. Long and his group agreed this might be possible.

The genetic engineering approach, if it works, may well be used in commercial seeds produced by Western agricultural companies. One of them, Snygenta, has already signed a deal to get a first look at the results. But the Gates Foundation is determined to see the technology, assuming its early promise is borne out, make its way to African farmers at low cost.

The work is, in part, an effort to secure the food supply against the possible effects of future climate change. If rising global temperatures cut the production of food, human society could be destabilized, but more efficient crop plants could potentially make the food system more resilient, Dr. Long said.

"We're in a year when commodity prices are very low, and people are saying the world doesn't need more food," Dr. Long said. "But if we don't do this now, we may not have it when we really need it."

1. Describe at least two advantages and disadvantages of green biotechnology! 2. Would you buy GM tomatoes? Give reasons for or against it! 3. Explain the process of photosynthesis! 4. Elucidate how they changed the process of photosynthesis! 5. Draw a conclusion! One person moderates the discussion by asking questions. The others are divided into the pro group and the contra group.

Act out the discussion. Make sure that you talk freely.

Find a word that has to do with green biotechnology. Restart with the last letter of the word with a new word that is related to green biotechnology. E.g. alteresilient 

Form the questions for the following answers. Ask for the underlined words.

1. I haven't seen him for ages. 2. He did his PhD in 2009. 3. Photosynthesis was not actually efficient. 4. Photosynthesis is often called "the equation that powers the world." 5. He gave the article to Bob. 6 . This article is the work of James. 7. We are here because we want to alleviate poverty.

8. These compounds are the basic energy for all cells. 9. A long road lay ahead before any results could be presented. 10. He opposed the trial because of his experience.

1. Ich denke der Autor möchte, dass der Leser … 2. Soweit mir bekannt ist … 3. Ich kann nicht verleugnen … 4. Es gibt mehrere Gründe für … 5. Nach meinem Standpunkt … 6. Wenn wir die Argumente näher betrachten … 7. Um es auf den Punkt zu bringen … 8. Ein gutes Beispiel für … 9. Dieses Beispiel veranschaulicht … 10. Es fällt mir schwer …

Green technology means to me….

Research in green technology comprises…..

Regarding the previous text I come to the conclusion that….

To patent GMO is for me….. 

White biotechnology deals with the use of biotechnological processes to produce food or drinks. For bread you need yeast, for wine you need fermentation. White biotechnology is nothing new but one of the ancient techniques of mankind. However the innovative aspect about white biotechnology is the fact that it is made more environmentally friendly. You use in your washing agents or washing powder enzymes that reduce the energy consumption. Since fossil fuels are running out, white biotechnology is becoming more and more important on an industrial scale.

The following text gives you an insight: The application of biotechnology to industrial production holds many promises for sustainable development, but many products still have to pass the test of economic viability.

For tens of thousands of years, humans relied on nature to provide them with all the things they needed to make themselves more comfortable. They wove clothes and fabrics from wool, cotton or silk, dyed them with colours derived from plants and animals. Trees provided the material to build houses, furniture and fittings. But this all changed during the first half of the twentieth century, when organic chemistry developed methods to create many of these products from oil. Oil-derived synthetic polymers, coloured with artificial dyes, soon replaced natural fibres in clothes and fabrics. Plastics rapidly replaced wood and metals in many consumer items, buildings and furniture. However, biology might be about to take revenge on these synthetic, petroleum-based consumer goods. Stricter environmental regulations and the growing mass of non-degradable synthetics in landfills have made biodegradable products appealing again. Growing concerns about the dependence on imported oil, particularly in the USA, and the awareness that the world's oil supplies are not limitless are additional factors prompting the chemical and biotechnology industries to explore nature's richness in search of methods to replace petroleum-based synthetics.

An entire branch of biotechnology, known as, white biotechnology is devoted to this. It uses living cells -from yeast, molds, bacteria and plants -and enzymes to synthesize products that are easily degradable, require less energy and create less waste during their production. This is not a recent development: in fact, biotechnology has been contributing to industrial processes for some time. For decades, bacterial enzymes have been used widely in food manufacturing and as active ingredients in washing powders to reduce the amount of artificial surfactants. Transgenic Escherichia coli are used to produce human insulin in large-scale fermentation tanks. And the first rationally designed enzyme, used in detergents to break down fat, was introduced as early as 1988. The benefits of exploiting natural processes and products are manifold: they do not rely on fossil resources, are more energy efficient and their substrates and waste are biologically degradable, which all helps to decrease their environmental impact. Using alternative substrates and energy sources, white biotechnology is already bringing many innovations to the chemical, textile, food, packaging and health care industries. It is no surprise then that academics, industry and policy makers are increasingly interested in this new technology, its economy and its contributions to a sound environment, which could make it a credible method for sustainable development.

One of the first goals on white biotechnology's agenda has been the production of biodegradable plastics. Over the past 20 years, these efforts have concentrated mainly on polyesters of 3-hydroxydacids (PHAs), which are naturally synthesized by a wide range of bacteria as an energy reserve and carbon source. These compounds have properties similar to synthetic thermoplastics and elastomers from propylene to rubber, but are completely and rapidly degraded by bacteria in soil or water. The most abundant PHA is poly(3-hydroxy-butyrate) (PHB), which bacteria synthesize from acetyl-CoA. Growing on glucose, the bacterium Ralstonia eutropha can amass up to 85 % of its dry weight in PHB, which makes this microorganism a miniature bioplastic factory.

A major limitation of the commercialization of such bacterial plastics has always been their cost, as they are 5-10 times more expensive to produce than petroleumbased polymers. Much effort has therefore gone into reducing production costs through the development of better bacterial strains, but recently a potentially friendly alternative emerged, namely the modification of plants to synthesize PHAs. A small amount of PHB was first produced in Arabidopsis thaliana after the introduction of R. eutropha genes encoding two enzymes that are essential for the conversion of acetyl-CoA to PHB (Poirier et al. 1992) . Monsanto (St. Louis, MO, USA) then improved this process in 1999. Although this new wave of polymers has enormous potential, the timing of its evolution is uncertain. After initial enthusiasm, Monsanto and AstraZeneca (London, UK) abandoned these projects due to cost concerns. "Producing biopolymers from plants is a promising and fascinating scientific challenge," said Yves Poirier from the Laboratory of Plant Biotechnology at the Institute of Ecology, University of Lausanne, Switzerland. He thinks that companies are reluctant to pursue these projects because they need long-term investments that do not meet the companies' financial and time schedules. "Further genetic modifications still need to be introduced in the plants for their improvement," he said, "and once these plants are created, they will require specific harvesting and treatment protocols, with respect to regular plants. All this translates into heavy investments in new infrastructures and processing systems and into a considerable amount of time." Eight to ten years is his rough estimate of how long it will be before plant-produced PHAs might become economically viable.

Plans to manufacture a T-shirt from corn sugar have reached the same impasse. Dupont (Wilmington, DE, USA), the company that invented nylon, has for many years been developing a polymer based on 1,3-propanediol (PDO), with new levels of performance, resilience and softness. Adding an environmentally responsible dimension to the production, Dupont's polymerization plant in Decatur, Illinois (USA) has now successfully manufactured PDO from corn sugar, a renewable resource.

But although their corn-based polymer, called Sorona R, is more environmentally friendly and has improved characteristics, it is again up to the markets to make it a success. "The company plans an effective shift from the petroleum-based production to the bio-based one," said Ian Hudson, Sorona R Business Director at Dupont, "but this will happen if the economic process and market demands justify the transition."

Cargil Dow (Minnetonka, MN, USA) has gone a step further. The company has developed an innovative biopolymer, NatureWorks TM, which can be used to manufacture items such as clothing, packaging and office furnishings. The polymer is derived from lactic acid, which is obtained from the fermentation of corn sugar. It has already been brought to the market effectively and has recently appeared in US grocery stores as a container for organic food.

Another product that could benefit greatly from innovative biotechnology is paper. Much of the cost and considerable pollution involved in the paper-making process is caused by 'krafting', a method for removing lignin from the wood substrate. Lignin is the second most abundant polymer in nature after cellulose and provides structural stability to plants. In view of the significant economic benefits that might be achieved, many research efforts went into reducing the amount of lignin or modifying lignin structure in trees, while preserving their growth and structural integrity. Genetically modified trees with these properties already exist (Hu et al. 1999; Chabannes et al. 2001; Li et al. 2003) , but money will probably not be made from them anytime soon. Although the paper industry could make a considerable profit by reducing production costs, no large projects in this direction have yet been undertaken. Alain Boudet, Professor at the Centre for Vegetable Biotechnology at the University Paul Sabatier (Castanet-Tolosan, France), identified two major roadblocks for the commercialization of transgenic wood. "First of all, trees with altered lingin will need more tests on their actual field performance outside the laboratory before being widely used," he explained. "Secondly, and with much more difficulty, it will be necessary to conquer the public's acceptance to yet new transgenic organisms and to the distribution of products deriving from them."

White biotechnology also concentrates on the production of energy from renewable resources and biomasses. Starch from corn, potatoes, sugar cane and wheat is already used to produce ethanol as substitute for gasoline -Henry Ford's first car ran on ethanol. Today, some motor fuel sold in Brazil is pure ethanol derived from sugar cane, and the rest has 20 % ethanol content. In the USA, 10 % of all motor fuel sold is a mixture of 90 % petrol and 10 % ethanol. According to the Organisation for Economic Co-operation and Development's 2001 report on biotechnology and industrial sustainability, the USA now has 58 fuel plants, which produce almost 6 billion litres of ethanol per year.

But turning starch into ethanol is neither the most environmentally nor economically efficient method, as growing plants for ethanol production involves the use of herbicides, pesticides, fertilizers, irrigation and machinery. Companies such as Novzymes (Bagsward, Denmark), Genencor (Palo Alto, CA, USA) and Madygen (Redwood City, CA, USA) are therefore exploring avenues to derive ethanol speci-fically from celluloid material in wood, grasses and, more attractively, agricultural waste. Much of their effort is concentrated on developing more effective bacterial cellulases that can break down agricultural waste into simple sugars to create a more plentiful and cheaper raw substrate for the production of ethanol.

Hopeful visionaries have already started to talk about a 'carbohydrate economy' replacing the old 'hydrocarbon economy'. However, "making biomass an effective feedstock is not a cheap process," reminded Kirsten Staer, Director of Stakeholder Communications at Novozymes. To get the production of biofuel up and running on a commercial basis, alongside the development of new feedstock collection systems and the creation of special production plants, a different pricing of biofuel will be required, she commented. "The price structure for fossil fuel is fixed in the market by regulatory frameworks. If the biofuel production is to be successful, it will be necessary to enforce policies that introduce subsidies to bioethanol production, for instance, or put taxes on fossil fuel production," Staer said.

This has not stopped J. Craig Venter from founding the Institute for Biological Energy Alternatives (IBEA) in Rockville, Maryland (USA) last year to advocate the production of cleaner forms of energy. IBEA recently received a US 53 million grant from the US Department of Energy, primarily to engineer an artificial microorganism to produce hydrogen. Deprived of the genes for sugar formation that normally use hydrogen ions, this organism could devote all of its energies to the production of excess hydrogen and, ideally, become a synthetic energy producer.

White biotechnology may also benefit medicine and agriculture. Vitamin B 2 (riboflavin), for instance, is widely used in animal feed, human food and cosmetics and has traditionally been manufactured in a six-step chemical process. At BASF (Ludwigshafen, Germany) more than 1000 tonnes of vitamin B2 are now produced per year in a single fermentation. Using the fungus Ahsbya gossypii as a biocatalyst, BASF achieved an overall reduction in cost and environmental impact of 40 %. Similarly, cephalexin, an antibiotic that is active against Gram-negative bacteria and is normally produced in a lengthy ten-step chemical synthesis, is now produced in a shorter fermentation-based process at DSM Life Sciences Products (Heerlen, The Netherlands). However, vitamin B2 is just a single success story -other vitamins and drugs are still cheaper to produce with classic organic chemistry than by innovative white biotechnology.

Nevertheless, the potential environmental benefits of shifting to biofeedstocks and bioprocesses are substantial, thinks Wolfgang Jenseit from the Institute for Applied Ecology (Freiburg, Germany). "The new bioproduction processes substitute complex chemistry reactions. This, of course, corresponds to significant energy and water savings" he explained. It also benefits the atmosphere: the carbon needed to make bioethanol from biomass was sequestered by plants from the atmosphere, so putting it back by burning ethanol does not add to global warming. Jenseit pointed out. This is certainly good news for the countries that committed to limiting greenhouse-gas emissions by ratifying the Kyoto treaty.

And the economic benefits are expected to follow. According to the global consultancy firm McKinsey & Company, white biotechnology will occupy up to 10-20 % of the entire chemical market in 2010, with annual growth rates of Euro 11-22 billion. Huge differences exist, however, in the ways white biotechnology is managed in Europe and the USA, says Jens Riese, a Frankfurt-based Principal Associate at McKinsey & Company. "First of all, the overall sum invested in the US in the white biotech business is 250 million USDollar, a sum which by far exceeds the total European investment", he said. "Probably driven by a stronger geopolitical will of becoming independent from fossil fuel import, the US has shown a clearer propensity in the development of such technologies. Europe, on the other hand, is culturally more cautious and less adventurous in accepting innovative methodologies."

But white biotechnology has drawn interest in Europe. "There is consciousness about the need for innovation in this direction," said Oliver Wolf, Scientific Officer at the Institute for Prospective Technological Studies in Seville, Spain. "Although as yet no specific legislation exists, important steps are being taken towards the promotion of white biotechnology in Europe." White biotechnology has potentially large benefits, both economically and environmentally for a wide range of applications. The way for its development is being paved, but it remains a relatively young technology that has to compete with a mature oil-based chemical industry that has had nearly a century to optimize its methods and production processes. Nevertheless, the growing concerns about the environment and the possibility of cheaper oil in the future make white biotechnology a serious contender.

1. Find a headline for each paragraph of the text. 2. State at least three innovations of white biotechnology, describe them more closely. 3 . Clarify what problems go along with new white biotechnological inventions? 4. Exemplify the reasons for the environmentally-friendliness of white biotechnology. 5. Some adversaries say that biofuel is not environmentally-friendly. Give reasons for this statement. 6. Illustrate the success of white biotechnology. Find arguments for your statement. 7. Comment on the differences between the USA and Europe regarding white biotechnology.

Decide whether the following "-ing"-forms are participles or gerunds, give reasons and translate the sentence into German.

1. Growing concern on the dependence on imported oil makes white biotechnology attractive. 2. The awareness that oil supplies are not limitless are factors prompting the biotechnology industry to explore nature's richness. 3. Biotechnology has been contributing to industrial processes for some time. 4. Bacterial enzymes have widely been used for the food manufacturing. 5. The benefits of exploiting natural processes are manifold. 6. Much effort has therefore gone into reducing production costs. 7. Producing biopolymers from plants is a scientific challenge. 8. The company having invented nylon has for many years been developing a polymer with new levels of performance, resilience and softness. 9. Many research efforts went into reducing the amount of lignin. 10. Trees with altered lignin will need more tests outside the laboratory before being widely used.

Ten words from the text are hidden. Can you find them all? 

Repetition of the vocabulary of red, blue, green and white biotechnology: Red biotechnology -Blue biotechnology -Green biotechnology -White biotechnology   100  100  100  100  80  80  80  80  60  60  60  60  40  40  40  40  20 20 20 20

Divide the class into two groups. The teacher names five German words in the four fields. The pupils have to translate them into English.

The most difficult word has 100 points. The less difficult one has 20 points. The winner is who has most words right. 

Grey biotechnology comprises all biotechnological procedures which are used for the preparation of drinking water, the purification of sewage, the restoration of contaminated grounds or the cleaning of exhaust gases. The procedure applied is mostly the fermentation that is the enzymatic transformation of organic substances. In other words grey biotechnology is concerned with the removal of pollutants and environmental biotechnology.

Grey biotechnology is an environmentally friendly way to remove contaminants by using microorganisms such as fungi, protozoa, bacteria, algae and viruses from water or soil. Around 140 million tonnes of synthetic polymers are produced each year. It takes centuries to decay them. The water pollution in seas and oceans is immense.

Therefore grey biotechnology is a real chance to treat contaminated soil, oil spillage and radioactive contamination.

Scientists have developed bacteria eating plastics (named Ideonella sakaiensis 201-F6).

Grey biotechnology is also used to protect indigenous fauna which is threatened by foreign plants called phytoremediation.

It is also used to remake former brownfields by enhancing bacterial degradation of contaminants and adding nutrients to the soil. This procedure is called bioremediation.

However it is not applicable for soil that contains cadmium or lead. A simple application of grey biotechnology is your compost in the garden. 

1. Give at least three applications of bioremediation. 2. Explain the advantage and disadvantage of bioremediation. 3. Find differences between white and grey biotechnology.

Match the sentences together by using an "-ing"-form:

1. Bioremediation is also applied to contaminated wastewater. It cleans the contaminated wastewater without aggressive chemicals. 2. Nutrients are added to the soil. It enhances degradation of contaminants. 3. Bioremediation is not a feasible strategy at sites with high concentrations of chemicals.

These chemicals contain lead. 4. Bioremediation take advantage of the metabolic process. It can degrade concentration of different contaminants. 5. The process of bioremediation involves the introduction of new organisms. It enhances the degradation rate of indigenous fauna. 

Imagine you work for a company which main focus is bioremediation. Draft an advertisement for their webpage.

How often is bioremediation applied? What is your estimation? 

Noun Verb Adjective purification -Reinigung to remediate -beseitigen enzymatic -enzymatisch sewage -Abwasser bioremediate -biosanieren feasible -machbar restoration -Sanierung to hasten -sich beeilen indigenous -einheimisch contamination -Verunreinigung to recover sth. -etw. zurückgewinnen aerobic -aerob exhaust gases -Abgase to discharge -entlassen anaerobic -anaerob adjustment -Angleichung to apply to -anwenden metabolic -metabolisch pollutants -Verunreiniger to pose -etw. darstellen accidental -zufällig bioremediation -Biosanierung to take advantage of -einen Vorteil haben/etw. ausnutzen uncommon -ungewöhnlich degradation rate -Abbaurate to recycle -wieder verwerten regulatory -behördlich effluents -Abwässer to perform -etw. durchführen toxic -giftig

Yellow biotechnology develops products for application in green, red and white biotechnology. E.g. it fights off pests on an environmentally friendly way by using peptides (green biotechnology) or it develops the inhibition of resistant antibiotics (red biotechnology). Furthermore it harnesses enzymes for the production of glutenfree food (white biotechnology). The name yellow derives from the substance hemolymph which is a substance similar to blood in insects and is yellow. Basically yellow biotechnology is concerned with food production.

As mentioned in our previous article, the biotechnology industry can be broken down into color categories based on the techniques or products involved in that sector. For example, blue biotechnology includes practices utilizing ocean resources, whereas red biotechnology is related to pharmaceutical products or biomedical engineering. Yellow biotechnology involves the use of bio-engineering to make food. A classic example of yellow biotech's adaption of natural resources for our palates is brewing beer -harnessing the natural yeast fermentation process to fuel college fraternities and connoisseurs alike. A current hot topic within the food industry and culture and therefore yellow biotech, is sustainability. It is well known that the meat industry, in particular, has a drastic, and pervasive, effect on local and global environments. 1 This damaging effect results from resource diversion used to create farms, as well as the subsequent byproducts and run off from their existence. 2 Deforestation, clean water usage, and heavy feed requirements are necessary to raise the livestock, while antibiotics, pesticides, animal waste, and hormones directly pollute land and water to maintain them. The meat industry overall is responsible, for up to 24 % of greenhouse gas emissions, with no sign of slowing down. 3 Despite the implications for both human health and the environment, meat demand is increasing even as our natural resources are diminishing.

However, from great demand comes great potential. Within the yellow biotech sector, biologists and foodies are rising to the challenge. One exciting company, founded by Dr. Mark Post, uses in vitro cell culture techniques on adult cow stem cells to manufacture bovine muscle tissue -aka hamburger meat. The end result lowers land use by up to 99 %, water use by 96 %, and greenhouse gas emissions by 96 % when compared to other animal meat products. 4 Dr. Post conducted this research at Maastricht University, Netherlands, and live aired the first tasting of his "test tube meat" made up of over 20,000 hand-cultured muscle strands. In August 2013, taste testers noted the lack of fat or juiciness, but gave full points for the mouth feel and definitively preferred the in vitro meat to a vegetable-based substitute.

Since then, Dr. Post has taken his technology towards the market with his company MosaMeat. The cost of the first hamburger was a daunting Euro 250,000 (over USD 311,000). According to the company however, many of these costs were due to standard academic laboratory fees and the overall cost of operating at such a small scale. Ideally, this could be remedied by scaling up production and further refining their growth process. Considering the company plans to go global to help fill the hunger gap, achieving efficiencies of scale is very much a part of their long term plans. Still, the company has a few things to work out moving forward on the science end. The current culture system requires fetal bovine serum to grow the cells into functional supplement used daily in cell culture labs, for a company intent on using as minimal animal products with the smallest environmental impact possible, the question remains if a synthetic serum might be able to take its place.

Overall, MosaMeat and other in vitro meat companies show huge potential and have momentum on their side. With the current rate of research and initial progress shown, both environmentalists and animal lovers, as cheap, sustainable hamburger on the table, without the costs to the animals or environment.

To see where in vitro meat might take us in the future, check out this website for Bistro in vitro. While none of the menu is available as of today, they show there's no limit to the possibilities that this new technology could bring -and that it may be closer to your menu you think. 

1. Explain the relationship between sustainability and yellow biotechnology! 2. Would you buy in vitro meat? 3. Evaluate the advantages and disadvantages of in vitro meat. 4. Do you think it is realistic in the future? 5. Find a headline for each paragraph!

Translate the German sentences into English. Use at least five phrases from 1 to 10 for drawing a conclusion about the text.

To comment texts linking words emphasize your versatility: First translate the linking words: 

Use the following topics and make up a sentence with a linking word:

1. Red biotechnology -Alzheimer E.g. the analysis of the genetic make up of a person is thus useful for the treatment of Alzheimer. 2. Green biotechnology -crops 3. Blue biotechnology -research of jellyfish 4. White biotechnology -fermentation 5. Grey biotechnology -purification 3. Despite the negative __________ of meat production, the meat production is increasing.

5. The long term plan is to stop __________ .

6. ________________ are people who are active in the protection of their sourrounding.

7. ____________ of the company is to minimize a negative impact on the environment. 8. ___________ meat is a good alternative for people who love animals.

9. This artificial meat is also called ____________ meat because it is produced in the laboratory. 10. A negative aspect is that you need _____________ to produce artificial meat. 

He gave me a book. me = indirect object book = direct object He called me a fool. Me = direct object Fool = object complement He was always a good student.

Good student = subject complement Decide whether the bold words are a direct object, an indirect object, an object complement or a subject complement.

2. He called this in vitro meat challenging. 3. MosaMeat shows huge potential. 4. Foodies will be made curious. 5. They will give him more orders.

Translate the proverbs.

1. To be between the devil and the deep blue sea. 2. All that glitters is not gold. 3. She is green with envy. 4. That is still a grey area. 5. She was caught red-handed. 6. I tickled pink. 7. I told her a white lie because I didn't want to hurt her. 8. She is yellow-bellied. 9. He blackmailed him. 10. I am always browned off when I see him. 11. He goes gathering orange blossoms.

Find other proverbs with colours by finding corresponding German proverbs in English.

Verb Adjective inhibition -Hemmung to harness -ernten resistant to -widerstandsfähig gegenüber yeast fermentation -Hefefermentation to feed -füttern pervasive -allgegenwärtig livestock -Viehbestand to manufacture -herstellen in vitro -in vitro demand -Nachfrage to lower -vermindern bovine -Rinderfoodies -Feinschmecker to emit -ausstoßen environmental -Umweltsubstitute -Ersatz to substitute -ersetzen sustainable -nachhaltig small scale -kleine Skala to work out -ausarbeiten current -aktuell bioengineering -Biotechnik to involve -einbeziehen subsequent -nachfolgend sustainability -Nachhaltigkeit to fuel -anheizen vegetable-basedgemüsebasierend byproduct -Nebenprodukt to run off -ausgehen synthetic -synthetisch

Brown biotechnology is a very up to date topic as droughts are increasing due to climate change. On the basis of genetically modified plants brown biotechnology deals with the research of drought resistant plants. 

When most of us think about the threats posed by climate change, events like floods, droughts, intense storms and hotter temperatures come to mind. These are all, according to the vast majority of scientists, exactly what we can expect to see more and more of. However, what is often overlooked are the sociopolitical consequences of these climatic changes, in other words, we tend to view these natural disasters in a vacuum without recognizing the myriad ways in which climate change is both directly and indirectly shaping economies, cultures and governments. This being the case, looking back at conflicts such as those in Syria and the Sudan, it has become increasingly clear that climate change played a role in triggering the instability that led to these conflicts. Which begs the question could these conflicts have been prevented through non-political measures that responded to changes in climate?

The answer increasingly seems to be yes. Further developments in biotechnology and a deeper understanding of what triggered the conflicts in Syria and Sudan point to novel prevention solutions grounded in modern agriculture. The arrival of genetically engineered (GE) drought-tolerant crops can withstand longer and more intense droughts could have the potential to prevent future conflicts.

Both the conflicts in Syria and the Sudan followed intense, climate change-induced drought periods that caused mass crop failures and famine. Beginning as early as 1998 and continuing into the 21st century, Syria and the surrounding region experienced a drought that, according to research published in the Journal of Geophysical Research, was the worst the region had experienced in 900 years.

The subsequent crop failure and famine eventually forced rural populations into urban centers to seek out food and better living conditions. The unfortunate result of this mass migration of people was the failure of Syrian cities to provide basic goods and services, leading to public unrest and eventually conditions ripe for civil war.

Had these farmers been better prepared to deal with years-long drought conditions, might Syria have avoided their civil war? The answer is not clear, as the conflict in Syria is complex and it is impossible to say whether it could have been prevented by any one action.

However, learning from Syria, we can assume that in the future, reducing the impacts of drought on particularly at risk populations through implementation of modern farming practices and the introduction of GE drought-tolerant crops could play a major role in preventing political instability.

Though there are few GE drought-tolerant crops on the market today, scientists all over the world are developing new crops in an effort to better prepare farmers for the increasingly severe droughts we expect to see.

Researchers at the University of Cape Town in South Africa are working to genetically engineer teff, an African grain important to many indigenous groups, in order to increase its ability to bounce back from water deprivation. The group intends to pull genes from a non-edible native plant, Myroflammus flabellifolius, which has the ability to enter dormancy during intense drought, but then bounce back in the event of rain. Small scale, public projects such as these that pinpoint specific crops in specific areas will be the key to combatting the effects of climate change.

Similarly, Xiaophang Yang at the Oakridge National Laboratory in Tennessee is attempting something more ambitious and wide reaching in this research on understanding how naturally drought-resistant plants use a different type of photosynthesis to endure the stressful conditions of drought. Yang's goal is to map the genetics behind agave plants method of photosynthesis, which differs from most plants, with the hope of one day introducing those genes into common crops. Not only would this allow for crops to withstand drought conditions, it would also open up new areas for farming that were once too dry.

As the genetic engineering of crops rapidly expands in the public sector, using GMOs as a tool for mitigating the effects of climate change will become a more and more potent option, offering hope for feeding a growing global population and serving as a stabilizing force in drought ridden parts of the world.

Josh Winkler is a freelance journalist who focuses on genetic engineering, the Anthropocerne and the outdoors industry. 

Present in a group of four a country which is concerned with droughts (Sambia, Mosambique, Botswana, South Africa, India, Chile, South Asia). 

Ethics derives from Greek 'ethos' which means custom, habit, character or disposition. Ethics is a set of moral principles, which defines what is good for individuals and society. These principles are influenced by our culture and religion e.g. you must not steal. It comprises aspects such as how to live a good life, what are our rights and responsibilities and the language of right and wrong as well as moral decisions what is good or bad. There are different categories of ethics: metha-ethic concerns the origin of ethical principles. Normative ethics establishes a set of criteria what is right or wrong. Applied ethics is concerned with up to date topics such as children soldiers. Violet biotechnology takes into consideration ethical and moral issues which occur by the modification of genes and thus leads to the problematic issues such as patent rights. 

Modern biotechnology, with its focus on molecular biology and its concern for increasing human health and life spans, is all about the future. This biotech future presses in daily, sparking imaginations. At the same time, it elicits wariness or even fear that humanity is gaining too much power or too little choice over human evolution and destiny. The political climate, permeated as it is by a ferocious "moral approach" to science policy, heightens this public concern. We seem to have lost our capacity for rational discourse in the public arena. The biotech industry has increasingly realized that not only regulatory schemes but also contentious public and political debate can either enable or constrain research and development. For better or worse, science is political.

Since the birth of Dolly the cloned sheep, public concern about advancing biotechnology has been enflamed by the suspicion that science is at the mercy of the technological imperative, the propensity to think that because something can be done, it is inevitable. This seemingly easy slide from can to will -because it is technically possible to clone a child into existence, it will become an everyday occurrence, for example -leaves some with a sense of fatedness, a sense that science is unstoppable. Hence, for those people, science is not a subject of ethical concern. In this view, at best, ethics takes a quietistic turn; at worse, it becomes completely irrelevant. A mantra of 'if we can, we inevitably will' places troubling limits on our critical thinking and moral imagination. We must recognize that the possible -however captivating, however daunting -is not inevitable.

As human biotech research continues, scientist and layperson alike have the opportunity to deliberate about the ethical ramifications of the possible futures opened by scientific research. The science of ethics asks us to justify our actions and account for our intentions. It is not enough just to intend the good or to do something to bring it about. We must give good reasons why we do what we do. In the realm of biotechnology, our reasoning needs to address three main areas:

Incentives or the ways that we encourage scientists to do particular kinds of research Intentions or the goals of that research Actions or the potential applications of research results When considering ethical reasons for our actions, it is prudent to avoid "the Dolly effect," that is, attempting to slam the ethical door well after the sheep has scurried away. The unanticipated arrival of new biotechnologies -from cloning to xenotransplantation -leaves the public, and the scientific community, without a framework for considering the attendant ethical issues. As we quickly learned after Dolly's birth announcement was published in the New York Times, paying close attention to the direction biotechnology is headed is infinitely better than potentially overreacting once it gets there. To avoid the Dolly effect, the biotech community must initiate ethical discussions within itself and with the wider public.

To that end, it is well to begin with some questions. Ethics is about questions: about who asks, what they ask for and how we as individuals and communities respond. In reference to biotechnology, what questions should be posed? What aspects should be considered?

Along with the "golly wow" response to biotech innovation, we must ask, what are the personal and social impacts of biotechnology? What are its potential impacts on our values, our virtues, and our relationships? Does a particular application of biotechnology protect or endanger human or individual rights? Are the benefits and burdens distributed fairly? Does biotechnology advance or impede the common good? What are the risks, burdens and benefits? On whom do they fall? How are they distributed? What is an acceptable way to achieve a given benefit? May we do anything, as long as the outcome is good on balance? Or are there limits on what we do, even in the name of human health? And, what -or whom -have we not thought about?

The first step in answering any of those questions is quite difficult for people not well-versed in human biology and genetics: get the facts. Many disagreements result from not grasping the facts of the matter. It is impossible to make sound judgements about the appropriate uses of genetic testing, for example, without understanding some genetic science and the nature of the information gathered through such testing. It is incumbent upon scientists and others working in biotechnology to educate the public in general, and the media in particular, about the scientific method and experimental results. The trend toward releasing experimental results to the press before publication in a peer-reviewed journal, which is problematic in and of itself, at least requires scientifically savvy journalists whose duty is, in turn, to provide an adequate set of facts to the public.

Of course, facts only describe what is; ethics deals with what ought to be. How do we responsibly move from what is to what ought to be? It is the job of philosophical ethics to provide standards that help us identify what ought to be done.

Utilitarianism: one way to think about "the ought" is through the lens of utility, which looks at various options for action, asking who will be affected and to what extent each stakeholder will be benefited or harmed. In the utilitarian view, an ethical action is the one that produces the greatest balance of good over harm or the greatest good for the greatest number of people. Regarding research in human molecular genetics, for example, the utilitarian might argue that the potential benefit of relieving human suffering outweighs the possible dangers of manipulating human genes and evolution through germ-line intervention.

Rights: A different approach presumes that what makes human beings more than mere things is our ability to choose freely what type of lives to lead and the right to have our choices respected. This view from rights describes an ethical action as that which protects people from being used in ways that they do not choose. Importantly, each human has a right not to be treated as means to another's end, even an undeniably good end. The right not to be used encompasses other rights: the right to be told the truth, the right to privacy and the right not to be harmed are among those particularly relevant to biotech research and genetic medicine. For example, respecting rights may set limits on human subject research in molecular genetics by requiring adequate informed consent including an honest assessment of risks and benefits, or it may require that experimental gene transfer therapy to be undertaken only as a last resort. In this view, actions that violate individual or human rights are wrong.

The justice approach to ethics is rooted in the principle of "treating equals equally and unequals unequally." Justice mandates fairness in that people must be treated the same way unless they differ in ethically relevant ways. For example, when two runners cross the finish line at the same time. It is unfair to award the blue ribbon to Jeff and not to Jake unless, for example, Jake has cheated.

The primary form of justice in medicine and medical research is distributive justice, which is concerned with the fair distribution of benefits and burdens across society. Distributive justice, which is concerned with the fair distribution of benefits and burdens across society. Distributive justice seeks clarity regarding those aspects of individuals and society that may justify drawing distinctions in how benefits and burdens are allocated. That is, it seeks to identify under what conditions treating unequals unequally would be justified. Such material conditions could include distribution based on determinations of need, social worth, contribution, or effort. For example, the principle of need would support mechanisms for providing access to cutting-edge treatments to all who would tangibly benefit irrespective of their ability to pay for them. A principle of contribution might suggest that a family who sponsored research into an illness might have more influence on the direction of the research and greater access to its fruits than the rest of us.

The common good rests on a vision of society in which all people join in the pursuit of shared values and aims. Because individual good is inextricably woven into the good of the whole community, pursuing the common good includes creating a set of general conditions that are equally to everyone's advantage. Together with respecting individual rights and freedoms, the common good approach requires that common goals, such as human health and well being, be pursued through biotech innovation and a stable health care infrastructure.

A consideration of virtue assumes that certain ideals allow for the full development of our humanity. A person who has inculcated these core ideals, or virtues, will do what is right when faced with an ethical choice. Virtues are dispositions that facilitate acting in ways that develop human potential and allow human flourishing. Virtues are good habits in that they are acquired through repetition and practice and, once acquired, they become characteristic of a person. Honesty, integrity, prudence, courage, wisdom and compassion are examples of virtues. Once a person has developed a virtuous character, his or her inclination is to act in ways consistent with ethical principles. In much the same way as Barry Bonds is inclined to hit home runs, the virtuous person will be inclined to tell the truth and act with compassion and courage.

Virtue ethics, with the emphasis on character and ideals, captures the idea of "the good scientist" -intelligent, honest, compassionate, determined -much more so than the principle-based approaches of utility, justice and rights. The development of pharmaceuticals for "compassionate use" echoes an ethics of virtue.

Those five approaches suggest that biotech ethics should ask five questions:

• What benefits and what harms can be predicted for biotech innovations in both the research and application phases, and which courses of action will result in the best consequences overall? It is important to remember that determining consequences is more or less a guessing game. In instances of profound uncertainty and sizable risk, it is best to err on the side of caution when calculating benefits and risks. Neither hopes nor fears should be over-sold. • Who are the ethically relevant stakeholders, and what rights do they have? Which course of action protects those rights? Is human dignity respected? The consideration of specific individual and group rights requires coming to grips with the right to health care -a right that Americans claim but which remains unfulfilled for many. • Which option treats everyone the same unless there is an ethically justified reason to treat them differently? Biotech justice might hold up "need" as a criterion for access to innovative treatments. • Which course of action seeks the common good? Certainly, the recent SARS epidemic has heightened concern for the health of the whole and for the creation of common conditions that maximize individual and communal well being. • Which option best develops virtues? And which virtues, such as trust and compassion, might be particularly relevant to biotech development and human health?

This framework for ethics does not offer an easy or automatic solution to ethical dilemmas. That is not its goal. The frame work helps identify what ethics requires of us: to consider benefits and burdens, rights and justice, virtues and the common good. Each of these approaches gives us key information about ethical options in a given situation. In the end, each of us brings our moral judgement to bear in carefully considering the facts of the matter and what is right-making and wrong-making about our options for acting. When we do this reasoning together, through public discourse, we have a chance to develop a healthcare vision for our society. Such a vision would provide the necessary -and currently absent -criteria for determining which research trajectories to follow and which to ignore.

As we deliberate, we have a further obligation. Because biotech innovations may eventually involve germ-line manipulation, the actions we take today may effect every future generation of human beings, making the coming generations stakeholders in our ethical analysis. Consideration of transgenerational consequences may impose limits on what we do now in the interest of those who come after us. Minimally, we should not knowingly inflict harm. Many indigenous peoples speak of responsibilities that extend to the next seven generations. There is moral wisdom for us in that approach. As we approach cutting-edge issues in biotechnology, this very ancient moral wisdom can serve us well. 4. If you publish a scientific article, it is given before to a scientist who works in the same field in order to receive an objective judgement. So the article is _____________. 5. Sometimes in research, scientists discover _____________ results which they have never thought about before. 6. At the beginning it was difficult for him to start a new research project, but now he _______________________. 7. It takes a very long time to understand this problem, but now he has ____________ the issue. 8. Not only consumers are clients of companies, there are many more ________________. 9. The first picture of a black hole could ____________ its existence. 10. Cloning babies __________ a moral wariness.

Fill in the right prepositions: 

You start with a sentence that has to do with violet biotechnology. Your neighbor has to continue with the end of the sentence. E.g. Moral issues are important in biotechnology. Biotechnology for me is a very exciting field of science. Science has the duty to be universal.

Imagine you are the CEO of a biotechnological company producing pharmaceuticals. Write a standard list for ethical values which are valid in your company and published on your homepage. Write about 10 sentences.

Nowadays ethics…

Applied ethics deals with…

The correlation between biotechnology and ethics… My conclusion about violet biotechnology is…

Noun Verb Adjective habitat -Beheimatung to comprise -beinhalten savvy -versiert ethics -Ethik to constrain -belegen ethical -ethisch disposition -Veranlagung to advance -voran schreiten regulatory -behördlich concern -Sorge to enflame -entzünden quiestic -quiestisch ramification -Verzweigung to justify -rechtfertigen troubling -problematisch reasoning -Beurteilung to attempt -versuchen critical -entscheidend framework -Rahmen to overact -überreagieren prudent -vorsichtig burden -Bürde to endanger -gefährden unanticipated -unvorhersehbar judgement -Beurteilung to impede -verhindern well-versed -erfahren issue -Fragestellung to concern -betreffen sound -richtig

Dark biotechnology takes the fact into account that biotechnological research could be abused to create pandemics such as ebola. Often terrorists are blamed to use biotechnological weapons, e.g. spreading deadly pathogens. But the point is that states all over the world produce biotechnological weapons although it is against the UN conventions.

In 2001 an anthrax attack was caused by a letter in the USA. Lateron it was proved that the stem of this deadly disease derived from an US laboratory of Dr. Bruce Ivins. It has never been proved how this pathogen escaped from this high-security laboratory.

Till today not much is known about dark biotechnology because it is also not wanted that too much is public about it.

Nowadays triggers for illnesses can be artificially produced in the laboratory to understand their mechanism that is to say that a virus can be created in the laboratory. On the one hand it is good for sciences, on the other hand this knowledge can be abused.

To keep these threats at bay the WHO published a guidance document called: "Responsible life sciences for global health security". Normally sciences aim at improving the health of animals, plants and humans. The document of the WHO would like to inform states and researchers about possible risks including misuse of sciences research and accidents. It proposes measures to minimize risks such as public health surveillance, using ethical platforms, support ethics education and training, boost discussions, make people responsible for their research, train people about new legislation, prevent the access to pathogens in laboratories, implement biorisk management, the willingness of steady improvement and control, using self-assessment questionnaires.

Another guideline is the Biological Weapons Convention of 1972 which came into force in 1975. Every five years the states meet for a control conference. However, there is no treaty about concrete agreements about disarmament.

The convention consists of 15 articles which obligates the signed parties to use no weapons containing microorganisms or any other biological substances or toxins or to store or buy them. They have to destroy all weapons and are not allowed to give it to a third party. In 2018 182 states signed this convention but not every state ratified it.

Vorrichtungen zur Wasserhaltung, zur Wetterführung oder zum Ein-und Ausfahren der Beschäftigten beschädigt oder zerstört und dadurch Leib oder Leben eines anderen Menschen gefährdet, wird mit Freiheitsstrafe von drei Monaten bis zu fünf Jahren bestraft.

(2) Der Versuch ist strafbar.

(3) Verursacht der Täter durch die Tat eine schwere Gesundheitsschädigung eines anderen Menschen oder eine Gesundheitsschädigung einer großen Zahl von Menschen, so ist auf Freiheitsstrafe von einem Jahr bis zu zehn Jahren zu erkennen. 

In each sentence is a mistake (grammar or spelling).

1. Reliable informations to find on this topic is very difficult. 2. The means to destroy ourselves are the other side of the medal. 3. Its synthesize was a breakthrough. 4. The researchers successful developed a vaccine. 5. He didn't submit the results to the authorities. 6. This knowledge gets more and more important. 7. The result is as important as his ones. 8. This misuse is known to scientists since centuries. 9. Gen modification can also be misused. 10. He is a very carefully scientist.

Find out which diseases are caused by bioweapons or which means are bioweapons or not, give reason for your statement! What are the triggers? * a) sarin e) equine encephalitis b) typhus f) cereal rust c) oroya fever g) arsine d) rainbow herbicides 

Bioinformatics is the use of informatics for biotechnologists to process their data in a quick and understandable why. Statistics and mathematics support bioinformatics. Therefore good knowledge of informatics is an indispensable competence for biotechnological assistants. That is why biotechnological assistants work in a lot of interdisciplinary fields. Nanobiotechnology also comprises gold biotechnology. Nanobiotechnology deals with tiny organisms (10 −9m ) and materials used for the industry. Biotechnological assistants use large databases to gain further knowledge. The researchers looked beyond clock genes, too. From the BABYDIET dataset, they found that 23 % of all genes examined varied with the seasons.

Grouping the seasonal genes from the BABYDIET cohort into categories, the researchers found that overall, pro-inflammatory gene expression rose in the winter and fell in the summer, following the same general expression pattern as ARNTL.

Next, the researchers turned to publicly available data from two additional studies, on diabetes and asthma, the latter a multi-center study involving participants of summer and winter gene expression observed in the BABYDIET cohort were reversed in the dataset from an Australian asthmatic cohort, indicating that the seasonal trends were consistent even across hemispheres. In an asthmatic cohort from Iceland, which undergoes periods of 24-hour sunlight, seasonal patterns were irregular.

Using genetic markers of each cell type, the team found that levels of individual blood cell types in the BABYDIET cohort seemed to vary by season. Examining the composition of blood donated to Cambridge Bioresource for research throughout the year confirmed that the makeup did vary seasonally.

In a population from The Bambia, a Western African country just north of the equator, the researchers examined patterns of cellular blood composition using data gathered through the Keneba Biobank, finding that the blood's cellular makeup was tied to the rainy season. The researchers hypothesized that these seasonal changes in the cellular composition of blood are the major drivers of the seasonal variation in gene expression.

Studying gene expression in biopsies of adipose tissue from an independent twin study also revealed seasonal gene-expression variation, extending this seasonal variation trend beyond blood and immune cells.

An outstanding question is whether expression levels of pro-inflammatory genes rise in the winter as an offensive measure against pathogens or as a response to heightened pathogen exposure. "That's the 'chicken and egg' argument," said Todd.

Knowledge of seasonal gene expression could potentially help researchers better understand and treat seasonal diseases. For example, it is known that death from cardiovascular disease is more likely in the winter when, according to this research, expression of pro-inflammatory genes is high.

'Our observations help explain why some chronic diseases are seasonal in that our immune systems are heightened to be pro-inflammatory so that when we have a cardiovascular disease, we're more prone to developing the pathology that might lead to cardiovascular death,' said Tod. "I'm sure that the greater infectious disease burden that we suffer is also a contributing factor to the changes that we've seen, I think it's both."

Add at least four advantages and disadvantages.

Advantages Disadvantages -Evaluating experiments with huge data is easier -More and more work is done by computers therefore less work remains for biotechnological assistants

Fill in the missing words from the text. 

The topic of orange biotechnology is the reflection about how to teach and what to teach about biotechnology due to the fact that biotechnology is a rather complex field with a lot of interdisciplinary connections. Although biotechnology is a very old science, the word biotechnology was for the first time created in 1919 by Karl Ereky, director of the cattle utilization cooperative who published a book with the title: "Biotechnology of meat, fat and milk production in agricultural large concerns for scientific sophisticated farmers". Teachers have a great responsibility regarding the viewpoint about biotechnology but also the media. Therefore to think about the consequences not only in teaching sciences but also in teaching other aspects related to it such as ethics is a crucial effect. Scientists, who are teaching biotechnology, have the aim to open the mind of young people for biotechnology and making biotechnology more public and young people interested in their subject.

Therefore pupils should do an evaluation about their perception about how and what they learn in the field of biotechnology in applying different methods to evaluate their experiences.

Choose a method how to evaluate teaching of biotechnology: Orange  biotechnoloy  100  100  100  100  100  100  80  80  80  80  80  80  60  60  60  60  60  60  40  40  40  40  40  40  20  20  20  20  20  20 Divide the class into two groups A and B. Each group can choose a field. 100 is the most difficult question. 20 is the easiest question. Who has answered most of the questions correctly has won. The teacher has to ask five questions for every field.

Bioeconomy represents the production of renewable biological resources into value added products such as food or biomass. Bioeconomy wants to reach the transition of the industry by using as less fossil fuels as possible. 

On the one hand, a bioeconomy relies on renewable resources to meet society's need for food, energy and industrial products. On the other, it emphasises the role of biogenic material flows. The bioeconomy model is expected to reduce our dependency on fossil fuels in the long term. In order to implement the shift from a fossil-based economy to a biobased economy on the regional level, the Baden-Württemberg government launched the Bioeconomy Research Strategy in summer 2013. It is a very large wheel that natural scientists, engineers, economists, ethicists, politicians and others are starting to turn. A wheel that, understandably, is only slowly gaining momentum. After all, it is a question of creating a whole new raw material basis for industry and the economy. It is about developing a new system in which science, industry and value creation interact in different ways than they did before. In the transition from a fossil-based to a biobased economy, oil, natural gas and coal will gradually become less important. These fossil fuels will be replaced by plants, plant residues, biowaste and other biobased materials.

More than ever before industry and science will have to act as a system, and previously non-existent connections will be established between different value creation chains.

Important economic factor: hydrocarbons The industrialization of the past 250 years is based on good ideas, drive and fossil fuels. Therefore, all industrialised economies are built on oil, gas and coal. Oil plays a particularly important role as it is used to produce organic chemicals, i.e. hydrocarbons. These are the basis for energy carriers such as petrol, diesel fuel and kerosene. Hydrocarbons form the economic basis of the chemical industry.

Solvents, paints, plastics, basic and fine chemicals, additives and many other products are produced from oil using complex, but well structured and established industrial processes. Moreover, our mobility, communication, nutrition, agriculture as well as the energy sector and others are directly dependent on fossil hydrocarbons. Our everyday life is unthinkable without fossil fuels -coal, oil and gas. Hydrocarbons are an important element of the economies of industrial countries where value is created by the efficacy with which hydrocarbons are converted into marketable products; they also make a decisive contribution to shaping the global economic system.

Four challenges If the vision of a bioeconomy is to become reality, it must not be based on replacing existing infrastructures. Instead a bioeconomy must be built on existing industrial processes. This means that it should initially offer drop-in solutions in order to gain a foothold in industry. At the same time, new processes, products and value creation chains need to be established. Four challenges need to be solved.

First: The bioeconomy must ensure a solid and reliable raw material base through agricultural and forestry production. These raw materials must be distributed in a way that assures human nutrition as well as taking into account all the economic sectors that use these raw materials.

Waste management is an important source of raw materials in a biobased economy. It can provide large quantities of biogenic waste -plant residues, fermentation residues, organic waste and material from landscape management. These materials can primarily be used for the production of energy, chemicals and materials. However, it will be necessary to adapt waste management material flows to the new value creation chains of the bioeconomy.

The second challenge relates to the conversion of biobased materials into hydrocarbons using so called conversion processes. Conversion processes can be seen as the bridge between petrochemistry and the new green chemistry. The production of hydrocarbons directly from biomass is already possible; however, the methods need to be further developed on a large industrial scale.

Conversion is only one field where a bioeconomy offers sales opportunities. Further potential lies in new materials. The fine-tuned process control of chemical, thermal and biotechnological process steps has the potential to release and use these potentials. One example is the biobased polyamide-5,10 developed by the Biopolymers/Biomaterials cluster.

The third challenge is sustainability. Sustainability is inseparable from bioeconomy. No sustainability, no bioeconomy. This statement underlies further fundamental requirements. Although some have been discussed and dealt with over the past years and decades, they need to occupy a more prominent place in discussions relating to the economy and industry of the future, and include such issues as the effective protection of the climate, water, soil as well as biodiversity. The objective of using raw materials from fields, forests and meadows for industrial production is more than ever associated with the need to manage and maintain the respective ecosystems. This includes rigorous protection of the climate, water, soil and biodiversity. This is where biodiversity research comes into play, which essentially means that the bioeconomy needs to promote a wide range of species, i.e. a biodiversity. It would be contradictory and dangerous for biodiversity if land-use methods that were focused simply on mass production were to be applied.

A bioeconomy also touches on ethical and social issues. Agricultural land is limited. We need to decide how much land is to be set aside for the production of food and feed, fuels and biobased materials. Against a background of hunger, species extinction, environmental and climate protection, the competition between food and fuel calls for a fundamental assessment of the respective fields of action in ethical terms. The Baden-Württemberg Bioeconomy Strategy Circle emphasi-ses that the transition to a biobased economy also needs to take social interest into account.

The fourth challenge is to convert technological solutions that are established in the different sectors of the bioeconomy into jobs, production plants, services and goods for export. This fulfills the economic and commercial aspects of a bioeconomy. In addition, criteria that enable the economic assessment of environmental and climate protection as well as biodiversity need to be developed. A bioeconomy also requires us to change our mindset. On the one hand, questions relating to immaterial values must be asked and answered and on the other hand, soft factors such as biodiversity need to be recognized as being able to create added value.

Bioeconomy research in Baden-Württemberg These challenges result in a considerable need for research. Scientists in Baden-Württemberg are investigating some of the topics that are of key importance in the transition from a fossil-based to a biobased economy.

The University of Hohenheim carries out research into biomass production, biomass potentials, land use, land-use changes and many other aspects associated with biobased raw materials. The Institute of Farm Management led by Prof. Dr. Enno Bahrs at the University of Hohenheim is mainly focused on efficiency. How can land be used efficiently? Which plants are best for which purpose? How must material flows and production systems be designed and implemented in order to achieve ideal efficiency?

Prof. Gero Becker from the Institute of Forest Utilisation and Work Science at the University of Freiburg is focused on research to improve the industrial utilisation of forest wood products. His research takes into account biomass quantities and resources as well as biomass quality in terms of conversion.

Professor Henning Bockhorn at the Karlsruhe Institute of Technology (KIT) has developed a method known as "biomass steam processing" that enables the production of biochar from residual biomass.

The transition to a biobased economy cannot be achieved without science and research, i.e. an increase in knowledge. This is why the term "knowledge-based bioeconomy (KBBE)" is often used. The Baden-Württemberg government launched the Baden-Württemberg Bioeconomy Research Programme in summer 2013, for which the Baden-Württemberg Ministry of Science, Research and the Arts will provide around 12 million euros between 2014 and 2019. Funding will be provided to research that is specifically focused on biogas, the use lignocellulose and the use of microalgae. 

Try to find out whether the following statements are true or false. If they are false correct the statements.

1. Bioeconomy takes time to be set into practice. 2. Green chemistry deals with the aim to be environmentally friendly and to reduce energy consumption as well as to create very cheap products. 3. A value creation chain includes different entrepreneurial activities such as production of goods, logistics, marketing, sales. 4. The Ministry is funding 12 million Euros for research about "knowledge-based bioeconomy" (KBBE). 5. Plastics are completely biodegradable. 6. Cosmetics contain partly oil. 7. Biomass consists out of plant and animal products which are used to generate energy. 8. Waste management has already reached the value creation chain. 9. Sustainability means that the regeneration of natural resources is guaranteed. 10. Prof. Becker does research about the usage of forest wood products.

Up at Least Five Sentences! E.g. a) bioplastics b) sustainable textiles c) bioactive (Further information: https://bmbf.de/upload_filestore/pub/Biooekonomie_in_Deutschland_ Engl.pdf)

Especially with respect to production of medicinal preparations, pharmaceutical companies are increasingly resorting to biological insights. Although chemically produced, medicine still represents the largest share on the German pharma market, so called biopharmaceuticals are increasingly gaining ground. Their sales of 5,5 billion euros are currently 21 % of the market, with a rising trend. These drugs consist of biomolecules that are so large that they cannot be manufactured by man -or only at prohibitive cost. These medications include antibodies against cancer and against auto-immune diseases such as multiple sclerosis, hormones such as insulin for treatment of diabetes and enzymes against metabolic diseases. Techniques from advanced biotechnology developed in the 1980s are applied for their production living microorganisms and cells can thereby be re-programmed as mini-factories (see action "The high-tech tools of bioeconomy"). Sources: p. 61 in https://bmbf.de/upload_filestore/pub/Biooekonomie_in_Deutsch-land_Engl. pdf

1. Bioeconomy is not only necessary because fossil fuels are running out but also because of other reasons. Give at least four other reasons. Explain them more closely. 2. How could a biobased product be introduced in a company, make up a suggestion concerning a) production b) sustainability c) waste management d) marketing

Excursion suggestion: Visit a bio economic company

Bioeconomy cares about _____________. So for example waste such as paper is reused to remake paper. The reuse of plastics or glass is part of the ___________________. The government ____________ all new inventions in the field of bioeconomy.

The products have to be tested in order to know whether they are _____________. Scientists ______________ new bioeconomic techniques. ____________ are used for biomass to create energy. ____________ energies are solar energy and wind energy. Industry and the government have to ________ with each other in order to boost bioeconomy.

Noun Verb Adjective material flow -Materialfluss to come into play -ins Spiel bringen renewable -erneuerbar conversion -Umwandlung to maintain -aufrecht erhalten biogenic -biogen sustainability -Nachhaltigkeit to promote -fördern biobased -biobasierend biowaste -Bioabfall to assess -bewerten marketable -marktfähig drop-in solution -vorübergehende Lösung to convert -umwandeln decisive -entscheidend plant residue -Pflanzenrückstand to investigate -erforschen residual -rückstandwaste management -Abfallmanagement to implement -einsetzen organic -organisch value creation chain -Wertschöpfungskette to provide -zur Verfügung stellen potential -potentiell biodiversity -Biodiversität to adapt -anpassen effective -effektiv resources -Resourcen to interact -interagieren exctinctiveauslöschend

What is your statement about the WHO guidelines and the Biological Weapons Convention of 1972?

What means 'to ratify'?

Do you think that biotechnology has a positive or negative image or both in public? Give reasons for it

Are you satisfied with the teaching methods about biotechnology? (Target)

Give at least three examples of products you use which are made out of fossil fuels. For each example give an idea how they could be replaced by other products

The author emphasizes four challenges. Please explain them more closely with your own words

Which aspects about bioeconomy do universities in Baden-Württemberg research about? 5. Why is biomass not environmentally-friendly?

Draw a conclusion about bioeconomy! Give your opinion about the success of bioeconomy

Strong decrease in lignin content without significant alteration of plant development is induced by simultaneous down-regulation of cinnamoyl CoA reductase (CCR) and cinnamyl alcohol dehydrogenase (CAD) in tobacco plants

White biotechnology

With an eye on hunger, scientists see promise in genetic tinkering of plants

Repression of lignin biosynthesis promotes cellulose accumulation and growth in transgenic trees

Yellow biotechnology application on the food industry through in vitro cell culture meats

Combinatorial modification of multiple lignin traits in trees through multigene cotransformation

Marine biotechnology: unknown sources of hope from depths of the sea. 08.10

Modern approaches to classification of biotechnology as a part of NBIC-technologies for bioeconomy

A Framework for Thinking Ethically About Human Biotechnology originally appeared in

The application of biotechnology to industrial sustainability

Parkinson's disease vitamin B3 has positive effect on nerve cells

Bioremediation: using living organisms to clean the environment

Polyhydroxybutyrate, a biodegradable thermoplastic produced in transgenic plants

Responsible life sciences research for global health security a guidance document

Seasonal genes

GMO crops could help stem famine and future global conflicts

The general framework for ethical decision making on which this article is based was developed by Manual Velasquez, Claire Andre, Thomas Shanks, and Michael J. Meyer and initially published under the title " 

Transfer the sentences either into the active or passive form.1. Researchers at the University of Cape Town are working to genetically engineer teff. 2. What is often overlooked are the sociopolitical consequences of climatic change. 3. Yang's goal is to map the genetics of agave plants. 4 . The crop failure forced rural populations into urban centers. 5. The genetic engineering of crops is rapidly being expanded by the public sector. 6. Genetically modified organisms withstand drought conditions. 7. Natural disasters are shaping economies. 8. Scientists all over the world are developing new crops. 9. He followed the rules of the modification of plants. 10 . Small scale projects will be the key for combatting droughts.

1. The fact that there is not enough to eat. 2. There is some food such as fly agaric which is poisonous and not possible to eat. 3. In Africa people who are natives and born in Africa are called a native group. 4. Due to droughts or floods there is no possibility to harness the crop. 5. Genetically modified crop is able to resist to droughts.

1. Explain the meaning of "the Dolly effect". 2. Do you agree with the statement of the author that science is political? Give reasons for yes or no. 3. The author mentions problems concerning ethical judgements. Go into detail. 4. Apply the three given points: incentives, intentions and actions to a research field. (An application is for example the research for vaccine). 5. Choose one question from page 81. E.g. What are the personal and social impacts of biotechnology? (An application is for example the research about inherited diseases). 6. Give reasons for non biotechnologists to find an ethical judgement and what does the author suggest what biotechnologists should do to make up the public think about it in a sophisticated way? 7. Exemplify the difference between utilitarianism and rights approach?

Make up a presentation in up to five persons about:1. What is the task of the German Ethics Council? (www.ethikrat.org) Draw a conclusion! 2. What is a patent? What are intellectual property rights? Should genes be patented? 3. What are the up-to-date law rules concerning gene technology in Germany? 4. Do a presentation about the EFSA!

Fill in the missing words:1. If you sell more machines in a week, the company grants you ______________. 2. This issue is not clear. Cloning is still a very __________ topic. 3. If you write about biotechnology, only very __________ journalists should write about it because it is a very complex topic.

Divide the class into four groups. The groups should do a presentation about:1. Responsible life sciences research for global health security 2. Biological and toxic weapon convention 3. Find out some bioweapons! 4. What can be done to avoid the use of bioweapons?

Find the right words in English. The number of the given letter forms a solution word.1. Biologische Kriegsführung -_______________________ 1 st letter 2. Impfstoff -__________________ 5 th letter 3. Krankheitserreger -____________ 5 th letter 4. fördern -_______________ 7 th letter 5. stärken -_______________ 8 th letter 6. strafbar -_____________ 6 th letter 7. Richtlinie -________________ 3 rd letter 8. bedeutsam -______________ 8 th letter 9. wissenschaftlich -______________ 1 st letter Solution word: ____________________________.

Write a summary about the article 314 criminal code ( 

Gene expression varies not only during the day but also throughout the year, a study shows.Gene expression in human immune cells varies by season according to a study published today (May 12) in Nature Communications -the first of its kind to examine patterns in gene-expression variation throughout the year.The results indicate "sort of a molecular signature of the season to humans," said Ghislain Breton, who studies circadian rhythm at the University of Texas at Houston, but was not involved in the work.In immune cells of the blood the expression of genes that promote information tends to rise in the winter and dip in the summer, the team led by investigators at the University of Cambridge -found. The researchers hypothesized that these and other seasonal gene expression pattern may help explain the seasonality of diseases, from infectious maladies like the flu to chronic conditions such as heart disease."We now know that all immune cell types have their own circadian clocks, as it is the case for virtually all other organs and cell types in the body," Nicolas Cermakian, who studies circadian rhythm at Douglas Mental Health University Institute and McGill University in Montreal, Canada, told The Scientist in an e-mail. " Moreover, the immune responses, controlled by the circadian clocks, vary according to the time of day," added Cermakian, who was not involved in the work. "What the new study…tells us is that timing information must be taken into account, when assessine gene expression and immune-related information, not only in the daily time scale, but also according to the time of year."Cambridge's Xaquin Castro Dopico, who earned his PhD in the lab of John Todd, was inspired to imitate this analysis after reading how expression of a repressor of inflammation in mice, ARNTL., varies throughout the day. At the time, the Todd lab was also collaborating with researchers in Germany on an ongoing study, called BABYDIET, examining the effects of a gluten-free diet during the first year of life on children's development and risk of Type 1 diabetes. BABYDIET requires regular collection of blood from participants over many years. So Castro Dopico used the data to ask "a different question," Todd recalled. "He said, I'll take this unique clinical dataset that we've generated and I'll ask the question: 'Does gene expression change not within a day but across the seasons?'"The team began by examining ARNTL expression in the BABYDIET cohort, finding that it had a strong seasonality, with levels rising in the summer and dropping in the winter. The researchers also looked at other clock genes and found that many of them (nine of 16) showed seasonal expression patterns. In medicine you take a small part of tissue to draw a conclusion for a certain disease. _________________________ 2. If you are not 100 % sure about a fact you suppose it might be true and you gather some facts to prove that it is true. __________________________ 3. You can divide the year into spring, summer, autumn and winter. __________________________ 4. If a scientist works on a certain topic for three years to gain new insights and afterwards he or she can name himself/herself a doctor. __________________________ 5. Genes which differ according to time and season. __________________________ Cermakian said it is too soon to consider the clinical utility of these findings. "What is sure," he noted, "is that timing information, circadian but also possibly seasonal/annual, will need to be taken into account more and more in the future, with the aim of providing the most adequate treatment to patients. The response to a treatment might be very different at one time of the year or six months later."

Verb Adjective data acquisition -Datenerwerb to promote -fördern circadian -zirkadian data processing -Datenverarbeitung to hypothesize -eine Hypothese aufstellen available -erhältlich computational biologycomputergestützte Biologie to provide -zur Verfügung stellen consistent -konsistent dataset -Datenset to maintain -aufrecht erhalten timing -zeitlich computing -Rechnerkapazität to install -installieren seasonal -saisonbedingt engineering -Technik to perform -ausüben cyber -Internet-EDP -electronic data processing -EDV -elektronische Datenverarbeitung to process -verarbeiten prevailingvorherrschend implementation -Implementierung to program -programmieren promoted -gefördert maintenance -Aufrechterhaltung to support -unterstützen wireless -kabellos performance -Leistung to transfer -übertragen computationalrechnergestützt